OREGON PUBLIC EMPLOYEES RETIREMENT FUND - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$448,095
-12.1%
16,253
-4.1%
0.01%0.0%
Q2 2023$509,607
-18.9%
16,953
-2.3%
0.01%
-25.0%
Q1 2023$628,699
+0.1%
17,353
-1.4%
0.01%0.0%
Q4 2022$627,899
+5.2%
17,603
-0.2%
0.01%0.0%
Q3 2022$597,000
+18.7%
17,633
+1.3%
0.01%0.0%
Q2 2022$503,000
-22.6%
17,408
-13.4%
0.01%
+14.3%
Q1 2022$650,000
+8.2%
20,108
-2.4%
0.01%0.0%
Q4 2021$601,000
+4.3%
20,608
-4.6%
0.01%0.0%
Q3 2021$576,000
-13.8%
21,608
-0.5%
0.01%0.0%
Q2 2021$668,000
+17.6%
21,7080.0%0.01%0.0%
Q1 2021$568,000
+6.0%
21,708
+1.9%
0.01%0.0%
Q4 2020$536,000
+18.8%
21,308
-1.5%
0.01%0.0%
Q3 2020$451,000
-9.8%
21,639
+2.9%
0.01%0.0%
Q2 2020$500,000
+32.3%
21,0390.0%0.01%0.0%
Q1 2020$378,000
-24.2%
21,0390.0%0.01%0.0%
Q4 2019$499,000
-13.7%
21,0390.0%0.01%
-12.5%
Q3 2019$578,000
-15.4%
21,039
+1.9%
0.01%
-11.1%
Q2 2019$683,000
-3.7%
20,639
+2.0%
0.01%
-10.0%
Q1 2019$709,000
+7.4%
20,239
+1.8%
0.01%0.0%
Q4 2018$660,00019,8730.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders